Trials / Conditions / Disruptive Behavior Disorder

Disruptive Behavior Disorder

16 registered clinical trials studyying Disruptive Behavior Disorder — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Evaluating Stress Management Strategies Within the School Readiness Parenting Program NCT06626750	Florida International University	N/A
Recruiting	Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents NCT06373484	Centre for Addiction and Mental Health	N/A
Completed	Addressing Depression and Positive Parenting Techniques (ADAPT) NCT04298437	Centre for Addiction and Mental Health	N/A
Unknown	Improving Social, Emotional, Behavioral, and Academic Functioning NCT05425381	East Carolina University	N/A
Unknown	Navigating Resource-Constrained Systems and Communities to Promote the Behavioral Health of Black Youth NCT04113161	Washington University School of Medicine	N/A
Recruiting	Clinical and Social Trajectories of Children and Adolescents With Disruptive Behavior NCT02812537	Hospices Civils de Lyon	—
Completed	Mindful Parenting and Parent Training Program Study NCT03796663	New York University	N/A
Completed	Mindfulness-based Program for Children With Disruptive Behavior Disorder NCT03698240	IRCCS Fondazione Stella Maris	N/A
Completed	Personalizing Psychosocial Intervention for Children With Disruptive Behaviour NCT07495683	Centre for Addiction and Mental Health	N/A
Completed	Behavioral Sleep Intervention in Children With Disruptive Behaviors NCT02783560	Indiana University	N/A
Completed	Enhancing the Outcomes of a Behavioral Parent Training Intervention NCT02704221	Christina Studts	N/A
Completed	Strongest Families Finland Canada: Family-based Prevention and Treatment Program of Early Childhood Disruptive NCT01750996	IWK Health Centre	Phase 1 / Phase 2
Completed	Addressing Behaviour and Treatment Effectiveness Project (A.B.A.T.E. Project) NCT02488499	Centre for Addiction and Mental Health	N/A
Completed	A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disru NCT00236470	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 3
Completed	A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disrupt NCT00250354	Janssen Pharmaceutica N.V., Belgium	Phase 3
Completed	A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in NCT00266552	Janssen Pharmaceutica N.V., Belgium	Phase 3